Rare diseases
Investigational molecules
Locations
Study on Epcoritamab, Rituximab, and Lenalidomide for Adults with Untreated Follicular Lymphoma
BelgiumStudy on Mosunetuzumab and Lenalidomide for Patients with Untreated Follicular Lymphoma
BelgiumStudy of ALX148 and Pembrolizumab for Patients with Advanced Head and Neck Cancer
BelgiumStudy on Rilvegostomig and Chemotherapy for Patients with Biliary Tract Cancer After Surgery
BelgiumStudy on the Safety and Effectiveness of TIN816 for Patients with Sepsis-Related Acute Kidney Injury
BelgiumStudy on Niraparib for Maintenance Treatment in Patients with Advanced Ovarian Cancer After Initial Chemotherapy Response
BelgiumStudy Comparing TAR-200 and Chemotherapy for Patients with High-Risk Non-Muscle-Invasive Bladder Cancer After BCG Treatment
BelgiumStudy on the Long-Term Safety of Povorcitinib for Patients with Moderate to Severe Hidradenitis Suppurativa
BelgiumStudy on the Safety and Effectiveness of Tovinontrine for Adults with Chronic Heart Failure with Reduced Ejection Fraction
BelgiumStudy of Trastuzumab Deruxtecan with or without Pertuzumab for Patients with HER2-positive Metastatic Breast Cancer
BelgiumStudy on Anifrolumab for Adults with Active Lupus Nephritis
BelgiumStudy of ALX148, Pembrolizumab, and Chemotherapy for Patients with Advanced Head and Neck Cancer
BelgiumTell us about your condition – we search every trial in Europe and connect you with the right site.
